Get the Stockscreener App
1.55
7.19%
-0.12
After Hours:
1.55
Vivos Therapeutics Inc stock is traded at $1.55, with a volume of 95,858.
It is down -7.19% in the last 24 hours and down -25.12% over the past month.
Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.
See More
Previous Close:
$1.67
Open:
$1.66
24h Volume:
95,858
Relative Volume:
0.75
Market Cap:
$17.70M
Revenue:
$14.58M
Net Income/Loss:
$-12.57M
P/E Ratio:
-0.2729
EPS:
-5.68
Net Cash Flow:
$-13.07M
1W Performance:
+3.33%
1M Performance:
-25.12%
6M Performance:
-67.37%
1Y Performance:
-60.05%
1-Day Range:
$1.5184
$1.66
1-Week Range:
$1.47
$1.88
52-Week Range:
$1.4235
$7.95
Vivos Therapeutics Inc Stock (VVOS) Company Profile
Name
Vivos Therapeutics Inc
Sector
Industry
Phone
(866)908-4867
Address
7921 SOUTHPARK PLAZA,, LITTLETON
Compare VVOS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VVOS
Vivos Therapeutics Inc
|
1.55 | 19.07M | 14.58M | -12.57M | -13.07M | -5.68 |
|
ABT
Abbott Laboratories
|
111.47 | 197.52B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
365.85 | 139.09B | 25.12B | 3.25B | 4.28B | 8.4018 |
|
MDT
Medtronic Plc
|
100.88 | 129.59B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.12 | 108.96B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
76.44 | 46.04B | 6.07B | 1.06B | 799.60M | 1.8527 |
Vivos Therapeutics Inc Stock (VVOS) Latest News
VIX Spike: How does Vivos Therapeutics Inc score in quality rankingsEarnings Growth Report & Expert Curated Trade Setups - baoquankhu1.vn
Gap Down: Is Vivos Therapeutics Inc part of any ETF2025 Technical Overview & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Earnings Update: How correlated is Vivos Therapeutics Inc to the S P5002025 Macro Impact & Fast Moving Trade Plans - baoquankhu1.vn
Vivos Therapeutics Appoints Gregg Johnson to Board - TipRanks
Vivos Therapeutics Appoints Gregg C. E. Johnson to Board of Directors - TradingView
Vivos Therapeutics, Inc. Appoints Gregg C. E. Johnson as Independent Director of the Board and Compensation Committee of the Board, Effective February 4, 2026 - marketscreener.com
Vivos Therapeutics to Distribute SoundHealth’s FDA-Cleared Sonu and Spatial Sleep Bands - HIT Consultant
Buyout Rumor: Will Vivos Therapeutics Inc benefit from government policyJuly 2025 Final Week & Stock Market Timing Techniques - baoquankhu1.vn
Vivos Therapeutics and SoundHealth collaborate to expand access to groundbreaking FDA-cleared allergy and sleep technologies - marketscreener.com
Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies - The Manila Times
Vivos Therapeutics Collaborates with SoundHealth to Enhance Airway and Sleep Health Solutions - Quiver Quantitative
Sound-based allergy and sleep bands join Vivos dentist network - Stock Titan
VIVOS Therapeutics, Inc. ($VVOS) Signs 12-Part Media Series with New to The Street - Eagle-Tribune
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains This Quarter - Benzinga
Vivos Therapeutics, Inc. (NASDAQ:VVOS) Receives $4.92 Consensus PT from Brokerages - Defense World
Treasury Yields: Is Vivos Therapeutics Inc part of any ETFQuarterly Market Review & Expert Approved Momentum Ideas - baoquankhu1.vn
Aug Catalysts: Is Vivos Therapeutics Inc showing insider buyingNew Guidance & Safe Entry Momentum Stock Tips - baoquankhu1.vn
What dividend growth rate does Vivos Therapeutics Inc. offer2025 AllTime Highs & Verified Stock Trade Ideas - mfd.ru
Income Plays: What is the PEG ratio of CHSCNMarket Risk Analysis & Reliable Price Breakout Alerts - baoquankhu1.vn
Global Sleep Apnea Devices Market is Expected to Cross the USD 15 Billion Mark by 2032 | DelveInsight - GlobeNewswire Inc.
Vivos Therapeutics Closes Exercise of 1.98M Warrants, Raising $4.64M - intellectia.ai
Vivos Therapeutics, Inc. Closes Exercise of Warrants Raising Approximately $4.64 Million for Working Capital - Quiver Quantitative
Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds - The Manila Times
Sleep apnea device maker Vivos raises $4.64M in repriced warrant deal - Stock Titan
Vivos Therapeutics Completes Warrant Inducement Financing Transaction - TipRanks
Vivos Therapeutics Signs Warrant Inducement Agreement With Institutional Investor - TradingView
Chipmakers Recap: What is the dividend yield of Vivos Therapeutics IncAnalyst Upgrade & Low Risk High Reward Ideas - baoquankhu1.vn
Vivos Therapeutics (NASDAQ:VVOS) and Akebia Therapeutics (NASDAQ:AKBA) Head to Head Contrast - Defense World
Vivos Announces Warrant Exercise Agreement - Dentistry Today
Vivos Therapeutics announces exercise of warrants for $4.64M gross proceeds - MSN
Vivos Therapeutics announces $4.64 million warrant exercise deal By Investing.com - Investing.com Nigeria
Vivos Therapeutics Secures Convertible Bridge Financing Facility - TipRanks
Vivos Therapeutics Signs Convertible Note Agreement With V-Co Investors 3 - TradingView
Vivos Therapeutics announces $4.64 million warrant exercise deal - Investing.com India
Vivos Therapeutics (VVOS) Exercises Warrants for $4.64M in Funding - Intellectia AI
Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds - The Manila Times
Sleep apnea device maker Vivos secures $4.64M from warrant exercise - Stock Titan
Dividend Watch: Is The Oncology Institute Inc Equity Warrants ROE strong enoughWeekly Earnings Recap & Weekly Momentum Picks - baoquankhu1.vn
Aug Summary: Is Vivos Therapeutics Inc part of any ETF2025 EndofYear Setup & Real-Time Volume Spike Alerts - baoquankhu1.vn
Alliance Global Partners Sticks to Its Hold Rating for Vivos Therapeutics (VVOS) - The Globe and Mail
Is Vivos Therapeutics Inc. stock a safe buy before earningsWeekly Stock Report & Long Hold Capital Preservation Tips - Улправда
Is Vivos Therapeutics Inc. stock a buy in volatile markets2025 Price Momentum & Weekly Stock Breakout Alerts - ulpravda.ru
Why analysts remain bullish on Vivos Therapeutics Inc. stockJuly 2025 Review & Safe Swing Trade Setup Alerts - Улправда
Can Vivos Therapeutics Inc. stock weather global recessionJuly 2025 Patterns & Growth Oriented Trade Recommendations - Улправда
Published on: 2026-01-08 23:11:17 - Улправда
Aug Update: Can Vivos Therapeutics Inc. stock weather global recessionPortfolio Profit Report & Fast Gaining Stock Reports - ulpravda.ru
Best Biotech Penny Stocks Right Now • Updated Daily - Benzinga
How Vivos Therapeutics Inc. stock compares to industry benchmarksUtilities Sector Analysis & See Risk Factors Before Making Any Move - Улправда
Vivos Therapeutics (VVOS) upgraded to buy: Here's what you should know - MSN
Vivos Therapeutics (VVOS) Upgraded to Buy: Here's What You Should Know - sharewise.com
Is Vivos Therapeutics Inc a good long term investmentProtective Put Strategies & Ride the Trends That Billionaires Follow - earlytimes.in
Vivos Therapeutics Inc Stock (VVOS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
0.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):